Evidence map›Paper›PMID 33685482›Full record

ArticleImmunity & ageing : I & A2020

Alterations of monocyte NF-κB p65/RelA signaling in a cohort of older medical patients, age-matched controls, and healthy young adults.

Juliette Tavenier, Line Jee Hartmann Rasmussen, Morten Baltzer Houlind, Aino Leegaard Andersen, Inge Panum, Ove Andersen, Janne Petersen, Anne Langkilde, Jan O Nehlin

Open access · goldAbstract read
In one paragraph

Article in Immunity & ageing : I & A, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Immune aging and infectious diseases.Chinese medical journal · 2024
    Review
  8. Review
  9. Article
  10. Aging and Inflammation.Cold Spring Harbor perspectives in medicine · 2024
    Review
  11. Article
  12. Review
  13. Post-translational modifications of p65: state of the art.Frontiers in cell and developmental biology · 2024
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Juliette TavenierDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark. juliette.tavenier@regionh.dk.
Line Jee Hartmann RasmussenDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark.
Morten Baltzer HoulindDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark.
Aino Leegaard AndersenDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark.
Inge PanumDepartment of Clinical Microbiology, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark.
Ove AndersenDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark. ove.andersen@regionh.dk.
Janne PetersenDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark.
Anne LangkildeDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark.
Jan O NehlinDepartment of Clinical Research, Copenhagen University Hospital Hvidovre, 2650, Hvidovre, Denmark.
Hvidovre Hospital · DKCopenhagen University Hospital · DKDuke University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAltered monocyte NF-κB signaling is a possible cause of inflammaging and driver of aging, however, evidence from human aging studies is sparse. We assessed monocyte NF-κB signaling across different aging trajectories by comparing healthy older adults to older adults with a recent emergency department (ED) admission and to young adults.

methodsWe used data from: 52 older (≥65 years) Patients collected upon ED admission and at follow-up 30-days after discharge; 52 age- and sex-matched Older Controls without recent hospitalization; and 60 healthy Young Controls (20-35 years). Using flow cytometry, we assessed basal NF-κB phosphorylation (pNF-κB p65/RelA; Ser529) and induction of pNF-κB following stimulation with LPS or TNF-α in monocytes. We assessed frailty (FI-OutRef), physical and cognitive function, and plasma levels of IL-6, IL-18, TNF-α, and soluble urokinase plasminogen activator receptor.

resultsPatients at follow-up were frailer, had higher levels of inflammatory markers and decreased physical and cognitive function than Older Controls. Patients at follow-up had higher basal pNF-κB levels than Older Controls (median fluorescence intensity (MFI): 125, IQR: 105-153 vs. MFI: 80, IQR: 71-90, p < 0.0001), and reduced pNF-κB induction in response to LPS (mean pNF-κB MFI fold change calculated as the log10 ratio of LPS-stimulation to the PBS-control: 0.10, 95% CI: 0.08 to 0.12 vs. 0.13, 95% CI: 0.10 to 0.15, p = 0.05) and TNF-α stimulation (0.02, 95% CI: - 0.00 to 0.05 vs. 0.10, 95% CI: 0.08 to 0.12, p < 0.0001). Older Controls had higher levels of inflammatory markers than Young Controls, but basal pNF-κB MFI did not differ between Older and Young Controls (MFI: 81, IQR: 70-86; p = 0.72). Older Controls had reduced pNF-κB induction in response to LPS and TNF-α compared to Young Controls (LPS: 0.40, 95% CI: 0.35 to 0.44, p < 0.0001; and TNF-α: 0.33, 95% CI: 0.27 to 0.40, p < 0.0001). In Older Controls, basal pNF-κB MFI was associated with FI-OutRef (p = 0.02).

conclusionsIncreased basal pNF-κB activity in monocytes could be involved in the processes of frailty and accelerated aging. Furthermore, we show that monocyte NF-κB activation upon stimulation was impaired in frail older adults, which could result in reduced immune responses and vaccine effectiveness.

Indexed as

AgingChronic inflammationImmunosenescenceInflammagingMonocyteNF-κB

Identifiers

PMID33685482
PMCPMC7938715
OpenAlexW3083355748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.